These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8579045)

  • 1. Verapamil and circadian variation of sudden cardiac death.
    Andersen L; Sigurd B; Hansen J
    Am Heart J; 1996 Feb; 131(2):409-10. PubMed ID: 8579045
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists. The prevention of a recurrent myocardial infarct and sudden death].
    Mazur NA; Vasil'eva NN; Pavlova TS; Kul'ginskaia IV; Zhdanova SM
    Ter Arkh; 1992; 64(9):50-3. PubMed ID: 1481155
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction.
    Hansen JF
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S20-5. PubMed ID: 1725912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case for the use of verapamil in alarming Chironex stings.
    Burnett JW
    Anaesth Intensive Care; 1998 Aug; 26(4):461-4. PubMed ID: 9743866
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
    Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O; Mortensen LS
    Am J Cardiol; 1997 Mar; 79(6):738-41. PubMed ID: 9070551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-channel blockers in postmyocardial infarction patients with special notation to the Danish verapamil infarction trial II.
    Gheorghiade M; Goldstein S
    Prog Cardiovasc Dis; 1991; 34(1):37-43. PubMed ID: 2063012
    [No Abstract]   [Full Text] [Related]  

  • 7. Verapamil in acute myocardial infarction. The Danish Multicentre Study Group.
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():89-96. PubMed ID: 6749352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.
    Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Bjergaard OP
    Am Heart J; 1997 Aug; 134(2 Pt 2):S48-52. PubMed ID: 9313623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS).
    Rengo F; Carbonin P; Pahor M; DeCaprio L; Bernabei R; Ferrara N; Carosella L; Acanfora D; Parlati S; Vitale D
    Am J Cardiol; 1996 Feb; 77(5):365-9. PubMed ID: 8602564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian variations in cardiac disease: clinical implications. Current strategies for preventing MI, dysrhythmias, sudden death.
    Lundberg GP; Liebson PR; Calvin JE
    J Crit Illn; 1995 Oct; 10(10):693-6, 699-700, 705-7. PubMed ID: 10155744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil following uncomplicated myocardial infarction: promising, but not proven.
    Yusuf S
    Am J Cardiol; 1996 Feb; 77(5):421-2. PubMed ID: 8602575
    [No Abstract]   [Full Text] [Related]  

  • 12. Angina pectoris, myocardial infarction and verapamil.
    Hansen JF; Mellemgaard K
    J Am Coll Cardiol; 1999 Sep; 34(3):957-8. PubMed ID: 10483985
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium channel blockers in the management of myocardial infarction patients.
    Gheorghiade M
    Henry Ford Hosp Med J; 1991; 39(3-4):210-6. PubMed ID: 1804826
    [No Abstract]   [Full Text] [Related]  

  • 14. "Cardioprotection"--not all calcium antagonists are created equal.
    Messerli FH
    Am J Cardiol; 1990 Oct; 66(10):855-6. PubMed ID: 2220585
    [No Abstract]   [Full Text] [Related]  

  • 15. Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):381-2. PubMed ID: 8364008
    [No Abstract]   [Full Text] [Related]  

  • 16. [Circadian rhythms in coronary heart disease. Their pathophysiology and significance for myocardial ischemia, acute myocardial infarct and sudden cardiac death].
    Zehender M; Hohnloser S; Just H
    Dtsch Med Wochenschr; 1992 Apr; 117(16):629-37. PubMed ID: 1568431
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic effects of tiapamil and verapamil in conscious rats following chronic myocardial infarction.
    Clozel JP
    Cardiology; 1988; 75(3):161-9. PubMed ID: 3416326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of calcium antagonists on long-term prognosis of patients with myocardial infarction].
    Novikova NA
    Kardiologiia; 2002; 42(3):62-3. PubMed ID: 12494189
    [No Abstract]   [Full Text] [Related]  

  • 20. Postinfarct treatment with verapamil. Effect of verapamil in patients with hypertension.
    Hansen JF
    Drugs; 1993; 46 Suppl 2():54-60. PubMed ID: 7512483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.